The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Oct 2017 10:52

RNS Number : 0865U
Midatech Pharma PLC
19 October 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Midatech Pharma Plc

549300GKR2G40H3QFY57

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

 

Legal & General Group Plc (Group)

 

Legal & General Investment Management Limited (LGIM)

 

City and country of registered office (if applicable)

1 Coleman St, London EC2R 5AA

4. Full name of shareholder(s) (if different from 3.)v

Name

 

Legal & General Assurance Society (LGAS)

 

City and country of registered office (if applicable)

1 Coleman St, London EC2R 5AA

5. Date on which the threshold was crossed or reachedvi:

17 October 2017

6. Date on which issuer notified (DD/MM/YYYY):

 

19 October 2017

 

 

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

L&G - 7.56%

-

L&G - 7.56%

61,034,135

 

Resulting situation on the date on which threshold was crossed or reached

LGIM - 16.83%

-

LGIM - 16.83%

61,034,135

 

Position of previous notification (if

applicable)

L&G - 5.07%

-

L&G - 5.07%

Position of previous notification (if

applicable)

LGIM - 10.35%

-

LGIM - 10.35%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD GBP 0.00005 (L&G Group)

4,616,706

-

7.56%

-

ORD GBP 0.00005 (LGIM)

-

10,275,518

-

16.83%

SUBTOTAL 8. A

10,275,518

16.83%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

x

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Legal & General Group (Direct/Indirect)

16.83%

16.83%

 

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

 

16.83%

 

16.83%

 

Legal & General Assurance Society (Direct)

7.56%

7.56%

 

 

Legal & General Group (Direct/Indirect)

16.83%

16.83%

 

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

 

16.83%

 

16.83%

Legal & General Assurance (Pensions Management) Limited

(Direct)

 

0.00%

 

0.00%

Legal & General Group (Direct/Indirect)

16.83%

16.83%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

 

16.83%

 

16.83%

Legal & General Investment Management Limited (Indirect)

 

16.83%

 

16.83%

Legal & General Group (Direct/Indirect)

16.83%

16.83%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

 

16.83%

 

16.83%

Legal & General (Unit Trust Managers) Limited (Indirect)

9.27%

9.27%

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

N/A

 

The number and % of voting rights held

N/A

 

The date until which the voting rights will be held

N/A

 

 

 

 

11. Additional informationxvi

 

 

Notification using the total voting rights figure of 10,275,518

 

 

Place of completion

Brunel House, 2 Fitzalan Road, Cardiff, CF24 0EB

Date of completion

19/10/2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMLBLTMBABMBR
Date   Source Headline
9th Jun 20208:24 amRNSForm 8.3 - Midatech Pharma plc
9th Jun 20208:10 amRNSForm 8.3 - Midatech Pharma plc
8th Jun 20207:00 amRNSResearch collaboration with Dr Reddy’s
1st Jun 202011:26 amRNSForm 8.3 - Midatech
29th May 202012:24 pmRNSForm 8.3 - Midatech Pharma plc
29th May 20209:59 amRNSHolding(s) in Company
28th May 20204:22 pmRNSForm 8.3 - Midatech Pharma Plc (Amended)
28th May 20204:00 pmRNSForm 8.3 - Midatech Pharma plc
28th May 20203:51 pmRNSForm 8.3 - [Midatech Pharma Plc]
28th May 20207:00 amRNSForm 8.3 - Midatech Pharma Plc
28th May 20207:00 amRNSForm 8.3 - Midatech Pharma Plc
27th May 20205:59 pmRNSForm 8.3 - Midatech Pharma PLC
27th May 20207:00 amRNSForm 8.3 - [Midatech Pharma plc]
26th May 20209:16 amRNSForm 8.3 - Midatech Pharma PLC
22nd May 20204:02 pmRNSForm 8.3 - Midatech Pharma plc
22nd May 20209:56 amRNSRule 2.9 Announcement
21st May 20207:01 amRNSRule 2.9 Announcement
21st May 20207:00 amRNSClosing of US$3.0m Registered Direct Offering
20th May 202011:36 amRNSForm 8.5 (EPT/RI)
19th May 202011:10 amRNSCorrection: UK Placing to Raise £1.8 million
18th May 20202:43 pmRNSUK Placing to Raise £1.8 million
18th May 20202:08 pmRNSUS$3.0 Million Registered Direct Offering
18th May 20207:00 amRNSHeadline Results for the Year Ended 31 Dec 2019
13th May 202011:28 amRNSForm 8.5 (EPT/RI)
12th May 20205:17 pmRNSAmendment to Relationship Agreement
5th May 202010:54 amRNSForm 8.3 - Midatech Pharma plc
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 202011:28 amRNSForm 8.5 (EPT/RI)
4th May 20207:00 amRNSForm 8 (OPD) (Midatech Pharma plc)
1st May 202011:08 amRNSStatement regarding Price Movement
30th Apr 20204:42 pmRNSSecond Price Monitoring Extn
30th Apr 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20208:56 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc Replacement
22nd Apr 20203:51 pmRNSRule 2.9 Announcement - Typo Correction
22nd Apr 202012:00 pmRNSForm 8.3 - Midatech Pharma Plc - Replacement
22nd Apr 202011:43 amEQSForm 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc
21st Apr 20203:20 pmRNSForm 8.3 - Midatech Pharma plc
20th Apr 20205:22 pmRNSRule 2.9 Announcement
20th Apr 20207:00 amRNSStrategic Review Update, Formal Sale Process
31st Mar 20207:00 amRNSStrategic Review, Update and Directorate Changes
2nd Mar 20203:48 pmRNSResult of General Meeting
2nd Mar 20207:00 amRNSMidatech Expands MTX110 DIPG Programme
13th Feb 20202:05 pmRNSSecond Price Monitoring Extn
13th Feb 20202:00 pmRNSPrice Monitoring Extension
12th Feb 20202:13 pmRNSNotice of General Meeting
8th Jan 20204:41 pmRNSSecond Price Monitoring Extn
8th Jan 20204:35 pmRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSPositive Results from MTD201-102 Study
16th Dec 20197:00 amRNSReceipt of NASDAQ Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.